Loading clinical trials...
Loading clinical trials...
It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.
Over the past year, an audit carried out on the Mercy maternity unit, covering 130 transfers to the Nancy regional maternity hospital, showed that patients transferred for threat of premature delivery (MAP) with a cervix \> 15 mm do not give birth at the receiving maternity unit, but return home after 48 hours' hospitalization. When maternal-fetal transfer (MFT) is requested, numerous calls are made to private ambulance services, and in the end, many emergency rapid response units (SMUR) are called out, requiring a major human, logistical and time investment for a questionable benefit to the patient. Tensions in terms of logistics (lack of ambulance, SMUR) and human resources (lack of personnel) can, conversely, compromise good care of the parturient.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Hopital Maillot
Briey, France
Maternité CH Léon Bourgeois
Châlons-en-Champagne, France
CHR Metz Thionville Hopital Femme Mère Enfant
Metz, France
Maternité - Hôpital Maurice Camuset
Romilly-sur-Seine, France
Clinique Saint Nabor
Saint-Avold, France
Matérnité Saint Dizier
Saint-Dizier, France
CHR Metz-Thionville Hopital Bel Air
Thionville, France
Hopital Saint Nicolas
Verdun, France
Start Date
April 1, 2024
Primary Completion Date
April 1, 2025
Completion Date
April 1, 2025
Last Updated
June 28, 2024
500
ESTIMATED participants
Maternal-fetal transfers
PROCEDURE
Lead Sponsor
Centre Hospitalier Régional Metz-Thionville
NCT06577922
NCT05804838
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions